Early steps in mammalian sex determination

Current Opinion in Genetics and Development

Volumn 6, Issue 3, 1996, Pages 316-321

  Ramkissoon, Yashin ^a   Goodfellow, Peter ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTIS DETERMINING FACTOR;

ADRENAL GLAND; GENE MUTATION; GONAD DEVELOPMENT; KIDNEY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SEX DETERMINATION; SEX TRANSFORMATION; SHORT SURVEY; STEROIDOGENESIS;

MAMMALIA;

EID: 0029943390     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80008-6     Document Type: Article

References (58)

1. Parkhurst SM, Meneely PM: Sex determination and dosage compensation: lessons from flies and worms. Science 1994, 264:924-932.
2. Schafer AJ: Sex determination and its pathology in man. In Advances in Genetics, vol 33. Edited by Hall JC, Dunlap JC. San Diego: Academic Press; 1995:275-329.
3. Goodfellow PN, Lovell-Badge R: SRY and sex determination in mammals. Annu Rev Genet 1993, 27:71-92.
4. Whitfield LS, Lovell-Badge R, Goodfellow PN: Rapid sequence evolution of the mammalian sex-determining gene SRY. Nature 1993, 364:713-715.
5. Tucker PK, Lundrigan BL: Rapid evolution of the sex determining locus in Old World mice and rats. Nature 1993, 364:715-717.
6. Harley VR, Lovell-Badge R, Goodfellow PN: Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 1994, 22:1500-1501.
7. Hawkins JR: Sex determination. Hum Mol Genet 1994, 3:1463-1467.
8. Tajima T, Nakae J, Shinohara N, Fujieda K: A novel mutation localized in the 3′ non HMG box region of the SRY gene in 46,XY gonadal dysgenesis. Hum Mol Genet 1994, 3:1187-1189.
9. Ferrari S, Harley VR, Pontiggia A, Goodfellow PN, Lovell-Badge R, Bianchi ME: SRY, like HMG1, recognizes sharp angles in DNA. EMBO J 1992, 11:4497-4506.
10. Giese K, Cox J, Grosschedl R: The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 1992, 69:185-195.
11. Pontiggia A, Rimini R, Harley VR, Goodfellow PN, Lovell-Badge R, Bianchi ME: Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J 1994, 13:6115-6124.
12. Teo SH, Grasser KD, Thomas JO: Differences in the DNA binding properties of the HMG box domains of HMG1 and the sex determining factor SRY. Eur J Biochem 1995, 230:943-950.
13. Capel B, Swain A, Nicolis S, Hacker A, Walter M, Koopman P, Goodfellow P, Lovell-Badge R: Circular transcripts of the testis-determining gene Sry in adult-mouse testis. Cell 1993, 73:1019-1030.
14. Koopman P, Munsterberg A, Capel B, Vivian N, Lovell-Badge R: Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 1990, 348:450-452.
15. Zwingman T, Fujimoto H, Lai LW, Boyer T, Ao A, Stalvey J, Blecher SR, Erickson RP: Transcription of circular and noncircular forms of Sry in mouse testes. Mol Reprod Dev 1994, 37:370-381.
16. Lovell-Badge R, Robertson E: XY female mice resulting from a heritable mutation in the primary testis determining gene, Tdy. Development 1990, 109:635-646.
17. Daneau I, Hoed A, Ethier JF, Lussier JG, Silversides DW: Bovine SRY gene locus: cloning and testicular expression. Biol Reprod 1995, 52:591-599.
18. Hacker A, Capel B, Goodtellow P, Lovell-Badge R: Expression of Sry, the mouse sex determining gene. Development 1995, 121:1603-1614. This paper describes the use of RNase protection to provide a detailed analysis of Sry expression in the mouse genital ridge. A comparison with Amh expression defines a window of 20 hours between 10.5 and 11.5 dρc during which Sry must act.
19. Lee CH, Taketo T: Normal onset but prolonged expression, of Sry gene in the B6.Y(DOM) sex reversed mouse gonad. Dev Biol 1994, 165:442-452.
20. Jeske YWA, Bowles J, Greenfield A, Koopman P: Expression of a linear Sry transcript in the mouse genital ridge. Nat Genet 1995, 10:480-482.
21. Boyer TR, Erickson RP: Detection of circular and linear transcripts of Sry in preimplantation mouse embryos -differences in requirement for reverse-transcriptase. Biochem Biophys Res Commun 1994, 198:492-496.
22. Qiu Ping C, Gaudette MF, Robinson DH, Crain WR: Expression of the mouse testis determining gene Sry in male preimplantatlon embryos. Mol Reprod Dev 1995, 40:196-204.
23. Fiddler M, AbdelRahman B, Rappolee DA, Pergament E: Expression of SRY transcripts in preimplantation human embryos. Am J Med Genet 1995, 55:80-84.
24. Clepet C, Schafer AJ, Sinclair AH, Palmer MS, Lovell-Badge R, Goodfellow PN: The human SRY transcript Hum Mol Genet 1993, 2:2007-2012.
25. Werner MH, Bianchi ME, Gronenborn AM, Clore GM: NMR spectroscoplc analysis of the DNA conformation induced by the human testis determining factor SRY. Biochemistry 1995, 34:11998-12004.
26. Werner MH, Huth JR, Gronenborn AM, Clore GM: Molecular basis of human 46,XY sex reversal revealed from the three dimensional solution structure of the human SRY DNA complex. Cell 1995, 81:705-714. The authors have used NMR to determine the solution structure of the HMG-box of human SRY in complex with DNA. This has been the first sequence-specific HMG box structure to be described and has provided an insight into how sex-reversing mutations of SRY affect its interaction with DNA.
27. Haqq CM, King C-Y, Ukiyama E, Falsafi S, Haqq TN, Donahoe PK, Weiss MA: Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY. Science 1994, 266:1494-1500.
28. Giese K, Pagel J, Grosschedl R: Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc Natl Acad Sci USA 1994, 91:3368-3372.
29. Dubin RA, Ostrer H: Sry is a transcriptional activator. Mol Endocrinol 1994, 8:1182-1192.
30. Cohen DR, Sinclair AH, McGovern JD: Sry protein enhances transcription of fos-related antigen-1 promoter constructs. Proc Natl Acad Sci USA 1994, 91:4372-4376.
31. Shen WH, Moore CCD, Ikeda Y, Parker KL, Ingraham HA: Nuclear receptor steroidogenic factor 1 regulates the Müllerian inhibiting substance gene: a link to the sex determination cascade. Cell 1994, 77:651-661. This paper provides evidence that Sf1 is a direct activator of MIS expression. In vitro experiments show that Sf1 binds upstream regulatory elements in the MIS gene and, in the presence of a Sertoli cell specific co-factor, can trans-activate expression.
32. Eicher EM, Washburn LL, Whitney JB, Morrow KE: Musposchiavinus Y-chromosome in the C57BL/6J murine genome causes sex reversal. Science 1982, 217:535-537.
33. Coward P, Nagai K, Chen D, Thomas HD, Nagamine CM, Lau YFC: Polymorphism of a CAG trinucleotide repeat within Sry correlates with B6.Y(Dom) sex reversal. Nat Genet 1994, 6:245-250.
34. Graves PE, Erickson RP: Sequence variation in the 5′, putative promoter of Sry and its possible relevance to the C57BL/6J Y(DOM) sex reversal. Biochem Biophys Res Commun 1995, 208:624-628.
35. Bennett CP, Docherty Z, Robb SA, Ramani P, Hawkins JR, Grant D: Deletion 9p and sex reversal. J Med Genet 1993, 30:518-520
36. Wilkie AOM, Campbell FM, Daubeney P, Grant DB, Daniels RJ, Mullarkey M, Affara NA, Fitchett M, Huson SM: Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature review. Am J Med Genet 1993, 46:597-600.
37. Tommerup N, Schempp W, Meinecke P, Pederson S, Bolund L, Brandt C, Goodpasture C, Guldberg P, Held KR, Reinwein H et al.: Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nat Genet 1993, 4:170-174.
38. Hovmoller ML, Osuna A, Eklof O, Fredga K, Hjerpe A, Lindsten J, Ritzen M, Stanescu V, Svenningsen N: Camptomelic dwarfism: a genetically determined mesenchymal disorder combined with sex reversal. Hereditas 1977, 86:51-62.
39. Houston CS, Opitz JM, Spranger JW, Macpherson RI, Reed MH, Gilbert EF, Herrmann J, Schinzel A: The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al. in 1971. Am J Med Genet 1983, 15:3-28.
40. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN et al.: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-530. See annotation [41••].
41. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Dagna-Bricarelli F, Keutel J, Hustert E et al.: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120. This study and [40••] describe translocation breakpoint mapping of sex-reversed CD patients. Mutation screening identified several heterozygous mutations of the SRY-related gene, SOX9, in both sex-reversed and non-sex-reversed CD individuals. This is evidence that CD s an autosomal dominant haplo-insufficiency syndrome and underlines the importance of gene dosage in sex-determining mechanisms.
42. Wright E, Hargrave MR, Christiansen J, Cooper L, Kun J, Evans T, Gangadharan U, Greenfield A, Koopman P: The Sry-related gene Sox-9 is expressed during chondrogenesis in mouse embryos. Nat Genet 1995, 9:15-20. This paper describes the expression pattern of mouse Sox9 during embryogenesis, emphasizing its rote in skeletal development. Strong expression of Sox9 at sites of chondrogenesis mirror the sites of skeletal malformation seen in the human syndrome campomelic dysplasia.
43. Ikeda Y, Lala DS, Luo X, Kim E, Moisan M-P. Parker KL: Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylases. Mol Endocrinol 1993, 7:852-860.
44. Ikeda Y, Shen W-H, Ingraham HA, Parker KL: Developmental expression of mouse steroidogenic factor 1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994, 8:654-662.
45. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490. This mouse knockout experiment of Sf1, known to be required for steroid hormone biosynthesis, demonstrates that the gene is also required for the development and maintenance of both the adrenal glands and the indifferent gonad. Mice deficient for Sf1 lack adrenal glands and gonads. The dual role of Sf1 in early gonadal formation and later in hormone production was unexpected.
46. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH et al.: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
47. Rose EA, Glaser T, Jones C, Smith CL, Lewis WH, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE: Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell 1990, 60:495-508.
48. Pelletier J, Schalling M, Buckler A, Rogers A, Haber DA, Housman D: Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 1991, 5:1345-1356.
49. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L et al.: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447.
50. Bardeesy N, Zabel B, Schmitt K, Pelletier J: WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 1994, 21:663-665.
51. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development Cell 1993, 74:679-691.
52. Arn P, Chen H, Tuck-Muller CM, Mankinen C, Wachtel G, Li S, Shen CC, Wachtel SS: SRVX, a sex reversing locus in Xp21.2→p22.11. Hum Genet 1994, 93:389-393.
53. Bardoni B, Floridia G, Guioli S, Peverali G, Anichini C, Cisternino M, Casalone R, Danesino C, Fraccaro M, Zuffardi O, Camerino G: Functional disomy of Xp22-pter in three males carrying a portion of Xp translocated to Yq. Hum Genet 1993, 91 ;333-338.
54. Bernstein R, Koo GC, Wachtel SS: Abnormality of the X chromosome in human 46,XY female with dysgenetic ovaries. Science 1980, 207:768-769.
55. Ogata T, Matsuo N: Testis determining gene(s) on the X chromosome short arm: chromosomal localisation and possible role in testis determination. J Med Genet 1994, 31:349.
56. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ERB, Fraccaro M et al.: A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994, 7:497-501.
57. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ERB et al.: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasla congenlta. Nature 1994, 372:635-641. This paper describes the cloning of DAX1 from the DSS-AHC critical region on the X. Mutations of DAX1 in AHC patients prove its identity as the adrenal hypoplasia congenita gene. DAXI is also a candidate for the X-linked dosage-sensitive sex-reversal gene and would encode a second nuclear hormone receptor (SF1 being the other) to be implicated in sex determination.
58. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G: Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996, 12:404-409. This paper describes the cloning and expression anajysis of mouse Dax1 In addition to transcription in the developing adrenal glands and hypothalamus, sexually dimorphic expression is seen in the gonad. Dax1 is down-regulated with overt differentiation of the testis in males, but persists in the developing ovary, providing circumstantial evidence for Dax1 being equivalent to DSS.